Celestica Falls 4% as Investors Appear to Take Profits Ahead of Late-October Updates
Investivoq PriceTracker
Celestica Inc. (CLS) is down 4.0% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver appears to be a mix of profit-taking and broader pressure on chip and AI-infrastructure names rather than any clearly negative company-specific announcement. This could be because Celestica had recently traded near fresh highs, while the company’s latest update simply set the date for its third-quarter results and investor day instead of adding a new operating catalyst.
Details:
Sources:
Celestica, SEC, AP, Nasdaq
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CLS Insider Trading Activity
$CLS insiders have traded $CLS stock on the open market 150 times in the past 6 months. Of those trades, 0 have been purchases and 150 have been sales.
Here’s a breakdown of recent trading of $CLS stock by insiders over the last 6 months:
- ROBERT MIONIS (Chief Executive Officer) has made 0 purchases and 109 sales selling 345,949 shares for an estimated $130,689,066.
- MANDEEP CHAWLA (Chief Financial Officer) has made 0 purchases and 39 sales selling 34,000 shares for an estimated $13,070,061.
- TODD C COOPER (President) sold 20,118 shares for an estimated $7,242,480
- MICHAEL MAX WILSON sold 4,168 shares for an estimated $1,389,236
To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.
$CLS Hedge Fund Activity
We have seen 497 institutional investors add shares of $CLS stock to their portfolio, and 333 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 3,874,584 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,413,448,243
- D. E. SHAW & CO., INC. added 1,782,300 shares (+1898.8%) to their portfolio in Q2 2026, for an estimated $650,183,040
- VIKING GLOBAL INVESTORS LP removed 1,654,989 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $603,739,987
- FMR LLC added 886,587 shares (+11.7%) to their portfolio in Q2 2026, for an estimated $323,426,937
- WINSLOW CAPITAL MANAGEMENT, LLC added 714,367 shares (+inf%) to their portfolio in Q2 2026, for an estimated $260,601,081
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 669,153 shares (-30.5%) from their portfolio in Q2 2026, for an estimated $244,107,014
- BLACKROCK, INC. removed 628,200 shares (-50.6%) from their portfolio in Q2 2026, for an estimated $229,167,360
To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.
$CLS Analyst Ratings
Wall Street analysts have issued reports on $CLS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Rothschild & Co issued a "Buy" rating on 05/01/2026
- JP Morgan issued a "Overweight" rating on 04/29/2026
To track analyst ratings and price targets for $CLS, check out Investivoq's $CLS forecast page.
$CLS Price Targets
Multiple analysts have issued price targets for $CLS recently. We have seen 10 analysts offer price targets for $CLS in the last 6 months, with a median target of $435.0.
Here are some recent targets:
- Mike Harrison from Rothschild & Co set a target price of $460.0 on 05/01/2026
- Tim Long from Barclays set a target price of $441.0 on 04/29/2026
- Mehdi Hosseini from Susquehanna set a target price of $510.0 on 04/29/2026
- Atif Malik from Citigroup set a target price of $415.0 on 04/29/2026
- John Shao from TD Cowen set a target price of $430.0 on 04/29/2026
- Paul Treiber from RBC Capital set a target price of $440.0 on 04/29/2026
- Samik Chatterjee from JP Morgan set a target price of $425.0 on 04/29/2026
This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.